Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
71
CCB Quote, Financials, Valuation and Earnings
Last price:
$80.82
Seasonality move
:
-4.31%
Day range:
$76.40 - $82.00
52-week range:
$35.67 - $86.27
Dividend yield:
0%
P/E ratio:
27.26x
P/S ratio:
2.50x
P/B ratio:
3.30x
Volume:
213.2K
Avg. volume:
112.7K
1-year change:
82.47%
Market cap:
$1.1B
Revenue:
$351.8M
EPS (TTM):
$2.97
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $50.3M | $65.3M | $101.8M | $213.6M | $351.8M | |
| Revenue Growth (YoY) | 24.79% | 29.85% | 55.98% | 109.8% | 64.72% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21M | $26.3M | $41.1M | $59.3M | $75.2M | |
| Other Inc / (Exp) | $171K | -$400K | $2.7M | -$153K | $279K | |
| Operating Expenses | $21M | $26.3M | $42.3M | $59.3M | $75.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $16.7M | $19.1M | $34.4M | $50.6M | $57.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.5M | $4M | $7.4M | $10M | $12.6M | |
| Net Income to Company | $13.2M | $15.1M | $27M | $40.6M | $44.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $13.2M | $15.1M | $27M | $40.6M | $44.6M | |
| Basic EPS (Cont. Ops) | $1.11 | $1.27 | $2.25 | $3.14 | $3.36 | |
| Diluted EPS (Cont. Ops) | $1.08 | $1.24 | $2.16 | $3.01 | $3.27 | |
| Weighted Average Basic Share | $11.9M | $11.9M | $12M | $12.9M | $13.3M | |
| Weighted Average Diluted Share | $12.2M | $12.2M | $12.5M | $13.5M | $13.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $23.2M | $24.8M | $38M | $71M | $148.8M | |
| Revenue (Reported) | $50.3M | $65.3M | $101.8M | $213.6M | $351.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $23.2M | $24.8M | $38M | $71M | $148.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $16.9M | $24.2M | $56.3M | $71M | $117.6M | |
| Revenue Growth (YoY) | 32.17% | 43.02% | 132.47% | 26% | 65.68% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6.7M | $11M | $16.6M | $20.5M | $19.8M | |
| Other Inc / (Exp) | -- | $1.5M | -$133K | $5K | $2K | |
| Operating Expenses | $6.7M | $11M | $16.6M | $20.5M | $19.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $5.2M | $8.6M | $14.1M | $13.1M | $16.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1M | $1.9M | $3M | $2.8M | $2.9M | |
| Net Income to Company | $4.1M | $6.7M | $11.1M | $10.3M | $13.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $4.1M | $6.7M | $11.1M | $10.3M | $13.5M | |
| Basic EPS (Cont. Ops) | $0.34 | $0.56 | $0.86 | $0.77 | $1.00 | |
| Diluted EPS (Cont. Ops) | $0.34 | $0.54 | $0.82 | $0.75 | $0.97 | |
| Weighted Average Basic Share | $11.9M | $12M | $12.9M | $13.3M | $13.4M | |
| Weighted Average Diluted Share | $12.2M | $12.5M | $13.5M | $13.7M | $13.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6.5M | $9.4M | $20.1M | $39.2M | $49.3M | |
| Revenue (Reported) | $16.9M | $24.2M | $56.3M | $71M | $117.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $6.5M | $9.4M | $20.1M | $39.2M | $49.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $59.9M | $85.3M | $176.7M | $324.8M | $444.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $24.6M | $36.8M | $55M | $72.8M | $77.5M | |
| Other Inc / (Exp) | -- | $2.3M | -$136K | $181K | $106K | |
| Operating Expenses | $24.6M | $38.1M | $55M | $72.8M | $77.5M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $17.8M | $31.3M | $44M | $60.8M | $52M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.7M | $7M | $9.2M | $12.1M | $11.1M | |
| Net Income to Company | $14.1M | $24.4M | $34.8M | $48.7M | $40.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14.1M | $24.4M | $34.8M | $48.7M | $40.9M | |
| Basic EPS (Cont. Ops) | $1.18 | $2.04 | $2.73 | $3.69 | $3.05 | |
| Diluted EPS (Cont. Ops) | $1.16 | $1.97 | $2.61 | $3.57 | $2.97 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $24M | $35.3M | $53.6M | $135.5M | $174.2M | |
| Revenue (Reported) | $59.9M | $85.3M | $176.7M | $324.8M | $444.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $24M | $35.3M | $53.6M | $135.5M | $174.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $46.5M | $66.5M | $141.4M | $252.6M | $345M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $19.2M | $29.8M | $43M | $56.5M | $58.8M | |
| Other Inc / (Exp) | -- | $2.7M | -$133K | $199K | $26K | |
| Operating Expenses | $19.2M | $31M | $43M | $56.5M | $58.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $13.2M | $25.4M | $35.1M | $45.3M | $40.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.8M | $5.7M | $7.6M | $9.7M | $8.3M | |
| Net Income to Company | $10.5M | $19.7M | $27.5M | $35.6M | $31.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $10.5M | $19.7M | $27.5M | $35.6M | $31.9M | |
| Basic EPS (Cont. Ops) | $0.88 | $1.65 | $2.13 | $2.68 | $2.37 | |
| Diluted EPS (Cont. Ops) | $0.86 | $1.59 | $2.04 | $2.61 | $2.31 | |
| Weighted Average Basic Share | $35.7M | $35.9M | $38.8M | $39.8M | $40.2M | |
| Weighted Average Diluted Share | $36.6M | $37.3M | $40.5M | $40.9M | $41.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $17.7M | $28.2M | $43.9M | $108.3M | $133.8M | |
| Revenue (Reported) | $46.5M | $66.5M | $141.4M | $252.6M | $345M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $17.7M | $28.2M | $43.9M | $108.3M | $133.8M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $127.8M | $163.1M | $813.2M | $342.1M | $483.1M | |
| Short Term Investments | $28.4M | $20.4M | $35.3M | $97.3M | $99.5M | |
| Accounts Receivable, Net | $3M | $8.6M | $9.4M | $28.2M | $35.9M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $159.2M | $192.1M | $857.9M | $467.7M | $618.5M | |
| Property Plant And Equipment | $21.6M | $24.2M | $23.3M | $23.2M | $28M | |
| Long-Term Investments | $37.2M | $29.3M | $45.1M | $108.9M | $160.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.1B | $1.8B | $2.6B | $3.1B | $3.8B | |
| Accounts Payable | $308K | $531K | $2.2M | $21.1M | $34.5M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $308K | $531K | $2.2M | $21.1M | $34.5M | |
| Long-Term Debt | $23.6M | $38.6M | $52.9M | $47.6M | $47.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1B | $1.6B | $2.4B | $2.9B | $3.5B | |
| Common Stock | $87M | $87.8M | $121.8M | $125.8M | $130.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $124.2M | $140.2M | $201.2M | $243.5M | $295M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $124.2M | $140.2M | $201.2M | $243.5M | $295M | |
| Total Liabilities and Equity | $1.1B | $1.8B | $2.6B | $3.1B | $3.8B | |
| Cash and Short Terms | $156.2M | $183.5M | $848.5M | $439.5M | $582.6M | |
| Total Debt | $23.6M | $38.6M | $52.9M | $47.6M | $47.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $182.2M | $669.7M | $410.7M | $474.9M | $484M | |
| Short Term Investments | $20.4M | $32.8M | $97.6M | $98.9M | $38K | |
| Accounts Receivable, Net | $8.2M | $7.5M | $67.5M | $34.1M | $39.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $210.8M | $710.1M | $575.8M | $607.9M | $523.8M | |
| Property Plant And Equipment | $24.3M | $23.6M | $23.8M | $26.7M | $31.3M | |
| Long-Term Investments | $29.7M | $43.3M | $109.5M | $153.4M | $59.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.7B | $2.5B | $3.1B | $3.7B | $4.1B | |
| Accounts Payable | $481K | $147K | $153K | $39.3M | $40.3M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $481K | $147K | $153K | $39.3M | $40.3M | |
| Long-Term Debt | $38.6M | $52.9M | $27.9M | $47.7M | $47.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.6B | $2.3B | $2.9B | $3.4B | $3.7B | |
| Common Stock | $87.5M | $89M | $123.9M | $129.2M | $134.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $135.2M | $161.1M | $228.7M | $284.5M | $331.9M | |
| Total Liabilities and Equity | $1.7B | $2.5B | $3.1B | $3.7B | $4.1B | |
| Cash and Short Terms | $202.6M | $702.6M | $508.3M | $573.9M | $484.1M | |
| Total Debt | $38.6M | $52.9M | $27.9M | $47.7M | $47.8M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $13.2M | $15.1M | $27M | $40.6M | $44.6M | |
| Depreciation & Amoritzation | $1.2M | $1.4M | $1.6M | $1.8M | $2.3M | |
| Stock-Based Compensation | $431K | $630K | $1.3M | $2.5M | $3.7M | |
| Change in Accounts Receivable | -- | -- | -$1.1M | -$9.2M | $1.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.7M | $19.3M | $29.8M | $67.1M | $196.5M | |
| Capital Expenditures | $1.2M | $5.4M | $2.6M | $2.8M | $6.2M | |
| Cash Acquisitions | -- | -- | -$20M | -- | -- | |
| Cash From Investing | -$164.5M | -$666.5M | -$239.6M | -$987.9M | -$599M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $230.6M | $24.3M | $19.6M | -- | |
| Long-Term Debt Repaid | -$10M | -$61.9M | -$163.7M | -$25M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $154.5M | $622.3M | $859.8M | $449.8M | $543.5M | |
| Beginning Cash (CF) | $40.3M | $43.9M | $163.1M | $813.2M | $342.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.6M | -$24.9M | $650M | -$471M | $141M | |
| Ending Cash (CF) | $43.9M | $19M | $813.2M | $342.1M | $483.1M | |
| Levered Free Cash Flow | $12.5M | $14M | $27.3M | $64.3M | $190.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.1M | $6.7M | $11.1M | $10.3M | $13.5M | |
| Depreciation & Amoritzation | $345K | $368K | $493K | $607K | $1.2M | |
| Stock-Based Compensation | $144K | $268K | $684K | $917K | $1.1M | |
| Change in Accounts Receivable | -- | -$472K | -$2M | $8.5M | -$4.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $4.9M | $12.5M | $21.2M | $65.1M | $63.4M | |
| Capital Expenditures | $558K | $392K | $290K | $2.2M | $2.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$83.3M | -$448.4M | -$156M | $7.6M | -$151.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $12.4M | $24.3M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$10M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $66M | $436.2M | $139.8M | $127.1M | $84.6M | |
| Beginning Cash (CF) | $26.5M | $31.5M | $405.7M | $275.1M | $487.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$12.4M | $249K | $5M | $199.9M | -$3.2M | |
| Ending Cash (CF) | $14.1M | $31.7M | $410.7M | $474.9M | $484M | |
| Levered Free Cash Flow | $4.3M | $12.1M | $20.9M | $62.9M | $60.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.1M | $24.4M | $34.8M | $48.7M | $40.9M | |
| Depreciation & Amoritzation | $1.3M | $1.6M | $1.8M | $2M | $3.9M | |
| Stock-Based Compensation | $520K | $1.1M | $2.2M | $3.5M | $4.2M | |
| Change in Accounts Receivable | -- | -- | -$5.5M | -$4.5M | -$5.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $17.2M | $29.7M | $48.6M | $171.3M | $248.1M | |
| Capital Expenditures | $5.1M | $2.8M | $3M | $4.1M | $9.2M | |
| Cash Acquisitions | -- | -$20M | -- | -- | -- | |
| Cash From Investing | -$695.4M | -$711.8M | -$435M | -$581.1M | -$577.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $227.6M | $27.3M | -- | -- | -- | |
| Long-Term Debt Repaid | -$20M | -$215.6M | -$25M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $645.4M | $699.7M | $621.3M | $474M | $338.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$32.7M | $17.6M | $234.9M | $64.2M | $9.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $12.2M | $26.9M | $45.6M | $167.2M | $238.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $10.5M | $19.7M | $27.5M | $35.6M | $31.9M | |
| Depreciation & Amoritzation | $965K | $1.2M | $1.3M | $1.6M | $3.1M | |
| Stock-Based Compensation | $414K | $902K | $1.8M | $2.8M | $3.4M | |
| Change in Accounts Receivable | -- | -$472K | -$4.9M | -$207K | -$7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $12.9M | $23.3M | $42M | $146.2M | $197.8M | |
| Capital Expenditures | $4.8M | $2.2M | $2.6M | $3.9M | $6.9M | |
| Cash Acquisitions | -- | -$20M | -- | -- | -- | |
| Cash From Investing | -$652.4M | -$697.6M | -$893M | -$486.2M | -$465.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $227.6M | $24.3M | -- | -- | -- | |
| Long-Term Debt Repaid | -$10M | -$163.7M | -$25M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $609.7M | $687.1M | $448.6M | $472.8M | $268.2M | |
| Beginning Cash (CF) | $84.5M | $67.3M | $1.9B | $1B | $1.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$29.8M | $12.8M | -$402.4M | $132.8M | $898K | |
| Ending Cash (CF) | $54.8M | $80M | $1.5B | $1.1B | $1.5B | |
| Levered Free Cash Flow | $8.1M | $21.1M | $39.4M | $142.3M | $190.9M | |
Get CCB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CCB
Sector
P/E ratio
27.26x
11.99x
PEG ratio
--
0.36x
P/B ratio
3.30x
1.05x
Price / LTM sales
2.50x
2.55x
Growth Metrics
CCB
Sector
Revenue growth
65.68%
6.08%
Earnings growth
29.33%
6.45%
Revenue (5-year growth)
54.26%
5.85%
Earnings forecast
$0.95
$0.56
Profitability
CCB
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
11.54%
5.27%
Return on assets
1.06%
0.98%
Return on equity
13.34%
9.43%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Jan
30
Estimated Next Earnings Date
Jan
27
Balance Sheet
CCB
Sector
Total cash
$484.1M
$615.3M
Short term investments
$99.5M
$408.4M
Total assets
$3.8B
$4.5B
Long term debt
$47.8M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
